What is a Patient Information Leaflet and why is it useful?

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Below is a text only representation of the Patient Information Leaflet. The original can be viewed in PDF format using the link above.

The text only version may be available from RNIB in large print, Braille or audio CD. For further information call RNIB Medicine Leaflet Line on 0800 198 5000. The product code(s) for this leaflet is: PL 01883/0327.

Ipinnia XL 2mg, 3mg, 4mg, 6mg and 8mg Prolonged-Release Tablets

INFORMATION FOR THE USER

Ipinnia® XL 2 mg prolonged-release tablets

Ipinnia® XL 3 mg prolonged-release tablets

Ipinnia® XL 4 mg prolonged-release tablets

Ipinnia® XL 6 mg prolonged-release tablets

Ipinnia® XL 8 mg prolonged-release tablets

Ropinirole

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
  • The full name of this medicine is Ipinnia® XL 2 mg, 3 mg, 4 mg, 6 mg and 8 mg Prolonged-release Tablets but within the leaflet it will be referred to as Ipinnia® XL.

What is in this leaflet

1. What Ipinnia® XL is and what it is used for
2. What you need to know before you take Ipinnia® XL
3. How to take Ipinnia® XL
4. Possible side effects
5. How to store Ipinnia® XL
6. Contents of the pack and other information

1. What Ipinnia® XL is and what it is used for

The active ingredient in Ipinnia® XL is ropinirole, which belongs to a group of medicines called dopamine agonists. Dopamine agonists affect the brain in a similar way to a natural substance called dopamine.

Ipinnia® XL is used to treat Parkinson’s disease. People with Parkinson’s disease have low levels of dopamine in some parts of their brains. Ropinirole has effects similar to those of natural dopamine, so it helps to reduce the symptoms of Parkinson’s disease.

2. What you need to know before you take Ipinnia® XL

Do not take Ipinnia® XL

  • if you are allergic (hypersensitive) to ropinirole or any of the other ingredients of this medicine (listed in section 6)
  • if you have a serious kidney disease
  • if you have a liver disease

Tell your doctor if you think any of these may apply to you.

Warnings and precautions

Take special care with Ipinnia® XL if you:

  • are pregnant or think you may be pregnant
  • are breast-feeding
  • are under 18 years old
  • have a serious heart complaint
  • have a serious mental health problem
  • have an intolerance to some sugars (such as lactose).

Tell your doctor if you experience symptoms such as depression, apathy, anxiety, fatigue, sweating or pain after stopping or reducing your ropinirole treatment. If the problems persist more than a few weeks, your doctor may need to adjust your treatment.

Tell your doctor if you think any of these may apply to you.

Your doctor may decide that Ipinnia® XL is not suitable for you, or that you need extra check-ups while you are taking it.

While you are taking Ipinnia® XL

Tell your doctor if you or your family/carer notices that you are developing urges or cravings to behave in ways that are unusual for you and you cannot resist the impulse, drive or temptation to carry out certain activities that could harm yourself or others. These are called impulse control disorders and can include behaviours such as addictive gambling, excessive eating or spending, an abnormally high sex drive or an increase in sexual thoughts or feelings. Your doctor may need to adjust or stop your dose.

Smoking and Ipinnia® XL

Tell your doctor if you start smoking, or give up smoking, while you are taking Ipinnia® XL. Your doctor may need to adjust your dose.

Other medicines and Ipinnia® XL

Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines, including medicines obtained without a prescription. Also remember to tell your doctor or pharmacist if you begin taking a new medicine while you are taking Ipinnia® XL.

Some medicines can affect the way Ipinnia® XL works, or make it more likely that you will have side effects. Ipinnia® XL can also affect the way some other medicines work.

These include:

  • the anti-depressant fluvoxamine
  • medication for other mental health problems, for example sulpiride
  • HRT (hormone replacement therapy)
  • metoclopramide, which is used to treat nausea and heartburn
  • the antibiotics ciprofloxacin or enoxacin
  • any other medicine for Parkinson’s disease.

Tell your doctor if you are taking, or have recently taken, any of these.

Ipinnia® XL with food and drink

You can take Ipinnia® XL with or without food, as you prefer.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Ipinnia® XL is not recommended if you are pregnant, unless your doctor advises that the benefit to you of taking Ipinnia® XL is greater than the risk to your unborn baby.

Your doctor will also advise you if you are breast-feeding or planning to do so. Ipinnia® XL is not recommended if you are breast-feeding, as it can affect your milk production. Your doctor may advise you to stop taking Ipinnia® XL.

Driving and using machines

Ipinnia® XL can make you feel drowsy. It can make people feel extremely sleepy, and it sometimes makes people fall asleep very suddenly without warning.

If you could be affected: do not drive, do not operate machines and do not put yourself in any situation where feeling sleepy or falling asleep could put you (or other people) at risk of serious injury or death. Do not take part in these activities until you are no longer affected.

Ropinirole can cause hallucinations (seeing, hearing or feeling things that are not there). If affected, do not drive or use machines.

Ipinnia® XL contain lactose and castor oil

Ipinnia® XL contains a type of sugar called lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking Ipinnia® XL.

Ipinnia® XL contains castor oil. May cause stomach upset and diarrhoea.

3. How to take Ipinnia® XL

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Use in children and adolescents

Do not give Ipinnia® XL to children. Ipinnia® XL is not normally prescribed for people under 18 years of age.

You may be given Ipinnia® XL on its own to treat the symptoms of your Parkinson’s disease. You may also be given Ipinnia® XL with another medicine called L-dopa (also called levodopa). If you are taking L-dopa you may experience some uncontrolled jerky movements when you first start taking Ipinnia® XL. Tell your doctor if this happens, as your doctor may need to adjust the dose of L-dopa you are taking.

How much Ipinnia® XL will you need to take?

It may take a while to find out the best dose of Ipinnia® XL for you.

The recommended starting dose of Ipinnia® XL is 2 mg once daily for the first week. Your doctor may increase your dose to 4 mg of Ipinnia® XL once daily, from the second week of treatment. If you are very elderly, your doctor may increase your dose more slowly. After that, the doctor may adjust your dose until you are taking the dose that is best for you.

Some people take up to 24 mg of Ipinnia® XL each day.

If at the start of your treatment you experience side effects that you find difficult to tolerate, speak to your doctor. Your doctor may advise you to switch to a lower dose of ropinirole film-coated (immediate-release) tablets which you will take three times a day.

It may take a few weeks for Ipinnia® XL to work for you. Do not take any more Ipinnia® XL than your doctor has recommended.

Method of administration

Take Ipinnia® XL once a day, at the same time each day.

Swallow your Ipinnia® XL tablet(s) whole, with a glass of water. Do not break, chew or crush them. If you do so, there is a danger you could overdose, because the medicine will be released into your body too quickly.

If you are switching from ropinirole film-coated (immediate-release) tablets

Your doctor will base your dose of Ipinnia® XL on the dose of ropinirole film-coated (immediate-release) tablets you were taking.

Take your ropinirole film-coated (immediate-release) tablets as normal the day before you switch. Then take your Ipinnia® XL the next morning and do not take any more ropinirole film-coated (immediate-release) tablets.

If you take more Ipinnia® XL than you should

Contact a doctor or pharmacist immediately. If possible, show them the Ipinnia® XL pack.

Someone who has taken an overdose of Ipinnia® XL may have any of these symptoms: feeling sick (nausea), being sick (vomiting), dizziness (a spinning sensation), feeling drowsy, mental or physical tiredness, fainting, hallucinations.

If you forget to take Ipinnia® XL

Do not take a double dose to make up for a forgotten tablet. If you have missed taking Ipinnia® XL for one day or more, ask your doctor for advice on how to start taking it again.

If you stop taking Ipinnia® XL

Do not stop taking Ipinnia® XL without advice. Take Ipinnia® XL for as long as your doctor recommends.

Do not stop unless your doctor advises you to. If you suddenly stop taking Ipinnia® XL, your Parkinson’s disease symptoms may quickly get much worse.

If you need to stop taking Ipinnia® XL, your doctor will reduce your dose gradually.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The side effects of Ipinnia® XL are more likely to happen when you first start taking it, or when your dose has just been increased. They are usually mild, and may become less troublesome after you have taken the dose for a while. If you are worried about side effects, talk to your doctor.

Very common: (affects more than 1 user in 10)

  • fainting
  • feeling drowsy
  • feeling sick (nausea).

Common: (affects 1 to 10 users in 100)

  • hallucinations (“seeing” things that are not really there)
  • being sick (vomiting)
  • feeling dizzy (a spinning sensation)
  • heartburn
  • stomach pain
  • constipation
  • swelling of the legs, feet or hands.

Uncommon: (affects 1 to 10 users in 1,000)

  • feeling dizzy or faint, especially when you stand up suddenly (this is caused by a drop in blood pressure)
  • feeling very sleepy during the day (extreme somnolence)
  • falling asleep very suddenly without feeling sleepy first (sudden sleep onset episodes)
  • mental problems such as delirium (severe confusion), delusions (unreasonable ideas) or paranoia (unreasonable suspicions).

Not known: (frequency cannot be estimated from the available data)

  • changes in liver function, which have shown up in blood tests.
  • hypersensitivity reactions including itchy skin rash, swollen face, lips, throat or tongue which may cause difficulty swallowing or breathing, rash and itching.
  • After stopping or reducing your Ipinnia® XL treatment: Depression, apathy, anxiety, fatigue, sweating or pain may occur (called dopamine agonist withdrawal syndrome or DAWS).

You may experience the following side effects:

Inability to resist the impulse, drive or temptation to perform an action that could be harmful to you or others, which may include:

  • Strong impulse to gamble excessively despite serious personal or family consequences.
  • Altered or increased sexual interest and behaviour of significant concern to you or to others, for example, an increased sexual drive.
  • Uncontrollable excessive shopping or spending
  • Binge eating (eating large amounts of food in a short time period) or compulsive eating (eating more food than normal and more than is needed to satisfy your hunger).

Tell your doctor if you experience any of these behaviours; they will discuss ways of managing or reducing the symptoms.

If you are taking Ipinnia® XL with L-dopa

People who are taking Ipinnia® XL with L-dopa may develop other side effects over time:

  • uncontrolled jerky movements are a very common side effect. If you are taking L-dopa you may experience some uncontrollable movements when you first start taking Ipinnia® XL. Tell your doctor if this happens, as your doctor may need to adjust the doses of the medicines you are taking.
  • feeling confused is a common side effect.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard

By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Ipinnia® XL

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister foil after EXP. The expiry date refers to the last day of that month.

Do not store above 30°C.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Ipinnia® XL contains

  • The active substance is ropinirole. Each prolonged-release tablet contains 2 mg, 3 mg, 4 mg, 6 mg or 8 mg of ropinirole (as hydrochloride).
  • The other ingredients are: hypromellose, croscarmellose sodium, maltodextrin; lactose monohydrate, hydrogenated castor oil, colloidal anhydrous silica, magnesium stearate; pigment blend:
    2 mg tablets: iron oxide red (E172), iron oxide yellow (E172), lactose monohydrate,
    3 mg tablets: lactose monohydrate, indigo carmine aluminium lake (E132), carmine (E120),
    4 mg & 8 mg tablets: iron oxide red (E172), iron oxide yellow (E172), lactose monohydrate, iron oxide black (E172).
    6 mg tablets: do not contain pigment blend.

What Ipinnia® XL looks like and contents of the pack

Ipinnia® XL 2 mg prolonged-release tablets are pink, mottled and oval with 2x debossed on one side.

Ipinnia® XL 3 mg prolonged-release tablets are purple, mottled and oval with 3x debossed on one side.

Ipinnia® XL 4 mg prolonged-release tablets are brown, mottled and oval with 4x debossed on one side.

Ipinnia® XL 6 mg prolonged-release tablets are white and oval with 6x debossed on one side.

Ipinnia® XL 8 mg prolonged-release tablets are dark pink, mottled and oval with 8x debossed on one side.

Pack sizes:

Ipinnia® XL prolonged-release tablets are available in blister packs of 21, 28, 30, 42, 56, 84 and 90 prolonged release tablets.

Not all pack sizes may be available.

Marketing Authorisation Holder

Macarthys Laboratories Ltd
T/A Martindale Pharma
Bampton Road
Harold Hill
Romford
Essex
RM3 8UG
United Kingdom

Manufacturer

Actavis Ltd
BLB 016 Bulebel Industrial Estate
Zejtun ZTN 3000
Malta

This leaflet was last revised in April 2018.

D50006